Adverum gene therapy trial sees disruption after serious side effect reported
Adverum Biotechnologies has reported a setback in its trial exploring gene therapy for the treatment of diabetic macular edema (DME).
Archives for April 29, 2021
Moderna ramps up COVID-19 vaccine supply to 3 billion doses in 2022
Moderna has announced a set of additional investments to allow it to increase global supply of its COVID-19 vaccine. ‘We believe there will continue to be significant need for our vaccine into 2022 and 2023’, says the company.
PureTech hails new avenue for Alzheimer’s disease treatment
Preclinical research, published in Nature, suggests a new avenue for Alzheimer’s disease (AD) treatment, through restoring lymphatic flow in the brain